KRYZA David

Fonction : Maitre de conférence

Spécialité :

Génie Pharmaceutique

Bureau : Rock

Téléphone : 04 78 78 29 06

EMail

47 documents

  • Kamel Chettab, Chantel Fitzsimmons, Alexey Novikov, Morgane Denis, Capucine Phelip, et al.. A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1066402⟩. ⟨hal-04112038⟩
  • David Kryza, Jennifer Wischhusen, Mathieu Richaud, Maëva Hervieu, Jacqueline Sidi Boumedine, et al.. From netrin‐1‐targeted SPECT / CT to internal radiotherapy for management of advanced solid tumors. EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩. ⟨hal-04107206⟩
  • Aurélie Moreau, Valentin Pretet, Emilie Paquet, Anne Laure Giraudet, David Kryza. Intense Diffuse Lung Uptake Due to Interstitial Pneumopathy Related to Polyangiitis Granulomata in 68Ga-PSMA-11 PET/CT. Clinical Nuclear Medicine, 2023, 48 (3), pp.261-263. ⟨10.1097/RLU.0000000000004408⟩. ⟨hal-04112054⟩
  • Valentina Andretto, Mathieu Repellin, Marine Pujol, Eyad Almouazen, Jacqueline Sidi-Boumedine, et al.. Hybrid core-shell particles for mRNA systemic delivery. Journal of Controlled Release, 2023, 353, pp.1037-1049. ⟨10.1016/j.jconrel.2022.11.042⟩. ⟨hal-04112050⟩
  • David Kryza, Aurélie Moreau, Jean Noël Badel, Thomas Mognetti, Anne Laure Giraudet. Unintentional Intra-arterial Injection of 177Lu-PSMA-1 in a Patient With a Peritoneal Carcinosis Secondary to a Metastatic Prostate Cancer. Clinical Nuclear Medicine, 2023, 48 (2), pp.203-205. ⟨10.1097/RLU.0000000000004492⟩. ⟨hal-04112042⟩
  • Silvia Breusa, Jean‐guy Delcros, Eloise Thomas, Serena Zilio, Diana Marcela Hernandez Palomino, et al.. Monoclonal antibodies decorated nanoparticles for the treatment of triple negative breast cancer. SFNano Annual Meeting, Dec 2022, Strasbourg, France. ⟨hal-03989500⟩
  • I. Andreana, E. Gazzano, E. Gianquinto, G. Piatti, V. Bincoletto, et al.. Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles. International Journal of Pharmaceutics, 2022, 625, pp.122102. ⟨10.1016/j.ijpharm.2022.122102⟩. ⟨hal-04112060⟩
  • Marie-Thérèse Aloy, Jacqueline Sidi Boumedine, Agathe Deville, David Kryza, Arnaud Gauthier, et al.. Proof of Concept of the Radiosensitizing Effect of Gadolinium Oxide Nanoparticles in Cell Spheroids and a Tumor-Implanted Murine Model of Chondrosarcoma. International Journal of Nanomedicine, 2022, Volume 17, pp.6655-6673. ⟨10.2147/IJN.S390056⟩. ⟨hal-04112046⟩
  • Joey Labour, Philippe Boissard, Thomas Baudier, Fouzi Khayi, David Kryza, et al.. Yttrium-90 quantitative phantom study using digital photon counting PET. EJNMMI Physics, 2021, 8 (1), pp.56. ⟨10.1186/s40658-021-00402-6⟩. ⟨hal-04112067⟩
  • Annalisa Rosso, Valentina Andretto, Yves Chevalier, David Kryza, Jacqueline Sidi-Boumedine, et al.. Nanocomposite sponges for enhancing intestinal residence time following oral administration. Journal of Controlled Release, 2021, 333, pp.579-592. ⟨10.1016/j.jconrel.2021.04.004⟩. ⟨hal-04112082⟩

Documents récupérés de l'archive ouverte HAL logo